Literature DB >> 19190528

Role of Ureaplasma species in neonatal chronic lung disease: epidemiologic and experimental evidence.

Rose Marie Viscardi1, Jeffrey D Hasday.   

Abstract

The contribution of Ureaplasma respiratory tract colonization to the pathogenesis of bronchopulmonary dysplasia in preterm infants has been debated for over 20 y. We review the current understanding of the role of inflammation in altered developmental signaling in the preterm lung and the evidence from human studies and experimental models that Ureaplasma-mediated inflammation produces the BPD phenotype. We propose that Ureaplasma infection initiated in utero and augmented postnatally by exposure to volutrauma and oxygen elicits a sustained, dysregulated inflammatory response in the immature lung that impairs alveolarization, and stimulates myofibroblast proliferation and excessive collagen and elastin deposition. Potential strategies to prevent or ameliorate the effects of Ureaplasma infection in utero and in the preterm lung are discussed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19190528      PMCID: PMC2920621          DOI: 10.1203/PDR.0b013e31819dc2f9

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  84 in total

1.  Amnionitis with Ureaplasma urealyticum or other microbes leads to increased morbidity and prolonged hospitalization in very low birth weight infants.

Authors:  Lieselotte Kirchner; Hanns Helmer; Georg Heinze; Martin Wald; Mathias Brunbauer; Manfred Weninger; Daniela Zaknun
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2006-11-13       Impact factor: 2.435

2.  Ureaplasma parvum lipoproteins, including MB antigen, activate NF-{kappa}B through TLR1, TLR2 and TLR6.

Authors:  Takashi Shimizu; Yutaka Kida; Koichi Kuwano
Journal:  Microbiology       Date:  2008-05       Impact factor: 2.777

Review 3.  Bronchopulmonary dysplasia and inflammatory biomarkers in the premature neonate.

Authors:  C L Bose; C E L Dammann; M M Laughon
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2008-08-01       Impact factor: 5.747

4.  Toll-like receptors and agonist responses in the developing fetal sheep lung.

Authors:  Noah H Hillman; Timothy J M Moss; Ilias Nitsos; Boris W Kramer; Cindy J Bachurski; Machiko Ikegami; Alan H Jobe; Suhas G Kallapur
Journal:  Pediatr Res       Date:  2008-04       Impact factor: 3.756

5.  Experimental amniotic fluid infection in sheep: effects of Ureaplasma parvum serovars 3 and 6 on preterm or term fetal sheep.

Authors:  Timothy J M Moss; Christine L Knox; Suhas G Kallapur; Ilias Nitsos; Christina Theodoropoulos; John P Newnham; Machiko Ikegami; Alan H Jobe
Journal:  Am J Obstet Gynecol       Date:  2008-01       Impact factor: 8.661

6.  The Alabama Preterm Birth Study: umbilical cord blood Ureaplasma urealyticum and Mycoplasma hominis cultures in very preterm newborn infants.

Authors:  Robert L Goldenberg; William W Andrews; Alice R Goepfert; Ona Faye-Petersen; Suzanne P Cliver; Waldemar A Carlo; John C Hauth
Journal:  Am J Obstet Gynecol       Date:  2008-01       Impact factor: 8.661

7.  Transition mutations in 23S rRNA account for acquired resistance to macrolides in Ureaplasma urealyticum.

Authors:  Meng Dongya; Xue Wencheng; Ma Xiaobo; Wang Lu
Journal:  Microb Drug Resist       Date:  2008-09       Impact factor: 3.431

8.  Developmental expression of Toll-like receptors-2 and -4 in preterm baboon lung.

Authors:  Shanjana Awasthi; Jodie Cropper; Kevin M Brown
Journal:  Dev Comp Immunol       Date:  2008-03-18       Impact factor: 3.636

9.  Certain type of chronic lung disease of newborns is associated with Ureaplasma urealyticum infection in utero.

Authors:  Yoko Honma; Yukari Yada; Naoto Takahashi; Mariko Y Momoi; Yoshikazu Nakamura
Journal:  Pediatr Int       Date:  2007-08       Impact factor: 1.524

10.  Differences in biofilm development and antibiotic susceptibility among clinical Ureaplasma urealyticum and Ureaplasma parvum isolates.

Authors:  María García-Castillo; María-Isabel Morosini; María Gálvez; Fernando Baquero; Rosa del Campo; María-Antonia Meseguer
Journal:  J Antimicrob Chemother       Date:  2008-08-27       Impact factor: 5.790

View more
  35 in total

1.  Pharmacokinetics, safety, and biologic effects of azithromycin in extremely preterm infants at risk for ureaplasma colonization and bronchopulmonary dysplasia.

Authors:  Hazem E Hassan; Ahmed A Othman; Natalie D Eddington; Lynn Duffy; Li Xiao; Ken B Waites; David A Kaufman; Karen D Fairchild; Michael L Terrin; Rose M Viscardi
Journal:  J Clin Pharmacol       Date:  2010-11-23       Impact factor: 3.126

2.  Frequency of ureaplasma serovars in respiratory secretions of preterm infants at risk for bronchopulmonary dysplasia.

Authors:  Tae-Jung Sung; Li Xiao; Lynn Duffy; Ken B Waites; Kirsty L Chesko; Rose M Viscardi
Journal:  Pediatr Infect Dis J       Date:  2011-05       Impact factor: 2.129

3.  Azithromycin to prevent bronchopulmonary dysplasia in ureaplasma-infected preterm infants: pharmacokinetics, safety, microbial response, and clinical outcomes with a 20-milligram-per-kilogram single intravenous dose.

Authors:  Rose M Viscardi; Ahmed A Othman; Hazem E Hassan; Natalie D Eddington; Elias Abebe; Michael L Terrin; David A Kaufman; Ken B Waites
Journal:  Antimicrob Agents Chemother       Date:  2013-02-25       Impact factor: 5.191

4.  A quantitative analysis of Ureaplasma urealyticum and Ureaplasma parvum compared with host immune response in preterm neonates at risk of developing bronchopulmonary dysplasia.

Authors:  Matthew S Payne; Kevin C W Goss; Gary J Connett; Julian P Legg; Ken D Bruce; Vicki Chalker
Journal:  J Clin Microbiol       Date:  2011-12-21       Impact factor: 5.948

Review 5.  Ureaplasma species: role in diseases of prematurity.

Authors:  Rose M Viscardi
Journal:  Clin Perinatol       Date:  2010-06       Impact factor: 3.430

Review 6.  Perinatal inflammation and lung injury.

Authors:  Rose Marie Viscardi
Journal:  Semin Fetal Neonatal Med       Date:  2011-09-08       Impact factor: 3.926

7.  Elevated high-sensitivity C-reactive protein in preterm infants with pulmonary colonization with Ureaplasma.

Authors:  John T Meadows; Benjamin T Kopp; Lori A Shook; Hubert O Ballard; Don Hayes
Journal:  J Thorac Dis       Date:  2013-06       Impact factor: 2.895

8.  Necrotizing enterocolitis is associated with ureaplasma colonization in preterm infants.

Authors:  Adora C Okogbule-Wonodi; George W Gross; Chen-Chih J Sun; Alexander G Agthe; Li Xiao; Ken B Waites; Rose Marie Viscardi
Journal:  Pediatr Res       Date:  2011-05       Impact factor: 3.756

Review 9.  Ureaplasma species: role in neonatal morbidities and outcomes.

Authors:  Rose Marie Viscardi
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2013-08-19       Impact factor: 5.747

10.  Suppression of antimicrobial peptide expression by ureaplasma species.

Authors:  Li Xiao; Donna M Crabb; Yuling Dai; Yuying Chen; Ken B Waites; T Prescott Atkinson
Journal:  Infect Immun       Date:  2014-02-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.